震不对称性和双边阶段特异性深度大脑刺激对姿势震的发展
Shenghong He1, Alceste Deli2, Timothy O West1,3
1Medical Research Council Brain Network Dynamics Unit, Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, UK.
概括
深度大脑刺激 (DBS) 有效地减少震不对称性在基本和 dystonic震患者. 双边相锁DBS显示不对称的效果,指导个性化治疗策略以改善结果.
科学领域:
- 神经科学是一个神经科学.
- 生物医学工程 生物医学工程
- 运动障碍 运动障碍
背景情况:
- 阶段锁定深度大脑刺激 (DBS) 提供了节能高效的震调节,用于基本的和 dystonic 震.
- 之前的研究主要探讨单边刺激,使得震不对称对双边相锁DBS的影响不清楚.
研究的目的:
- 在接受连续高频 DBS (cDBS) 的基本震患者中调查震不对称性.
- 探索双边相锁DBS对震不对称的作用,在基本和 dystonic震患者.
主要方法:
- 分析了九名基本震患者的四肢加速数据,以评估震幅度,频率和不稳定性不对称性.
- 双边相锁DBS的测试在一个基本震和一个反震患者中.
主要成果:
- 姿势震表现出不对称性,更大的功率与肢体的振幅和频率不稳定性相对应.
- cDBS显著减少了这些震动不对称性,对更大的振幅震动产生了更明显的影响.
- 双边相锁DBS显示对减轻震有不对称的影响.
结论:
- 震不对称是影响DBS有效性的关键因素.
- 这些发现为开发针对患者的适应性DBS疗法提供了洞察力.
- 这项研究促进了对DBS在管理不对称震症状方面的理解.
更多相关视频
07:14A Novel Approach to Assess Motor Outcome of Deep Brain Stimulation Effects in the Hemiparkinsonian Rat: Staircase and Cylinder Test
Published on: May 31, 2016
14.9K
14:14Targeting Neuronal Fiber Tracts for Deep Brain Stimulation Therapy Using Interactive, Patient-Specific Models
Published on: August 12, 2018
9.0K
相关概念视频
01:24Parkinson's Disease: Treatment
391
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
391
01:15Parkinson's Disease: Overview
722
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
722